nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycopyrrolate—CHRM4—Nicardipine—hypertension	0.116	0.274	CbGbCtD
Glycopyrrolate—CHRM5—Nicardipine—hypertension	0.113	0.268	CbGbCtD
Glycopyrrolate—CHRM3—Nicardipine—hypertension	0.0724	0.171	CbGbCtD
Glycopyrrolate—CHRM1—Nicardipine—hypertension	0.063	0.149	CbGbCtD
Glycopyrrolate—CHRM2—Nicardipine—hypertension	0.0581	0.137	CbGbCtD
Glycopyrrolate—Rash—Doxazosin—hypertension	6.93e-05	0.000185	CcSEcCtD
Glycopyrrolate—Fatigue—Losartan—hypertension	6.93e-05	0.000185	CcSEcCtD
Glycopyrrolate—Dermatitis—Doxazosin—hypertension	6.93e-05	0.000185	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Hydrochlorothiazide—hypertension	6.93e-05	0.000184	CcSEcCtD
Glycopyrrolate—Vomiting—Fosinopril—hypertension	6.91e-05	0.000184	CcSEcCtD
Glycopyrrolate—Nausea—Propranolol—hypertension	6.89e-05	0.000184	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Ramipril—hypertension	6.89e-05	0.000184	CcSEcCtD
Glycopyrrolate—Oedema—Ramipril—hypertension	6.89e-05	0.000184	CcSEcCtD
Glycopyrrolate—Headache—Doxazosin—hypertension	6.89e-05	0.000184	CcSEcCtD
Glycopyrrolate—Dry mouth—Timolol—hypertension	6.87e-05	0.000183	CcSEcCtD
Glycopyrrolate—Pain—Losartan—hypertension	6.87e-05	0.000183	CcSEcCtD
Glycopyrrolate—Constipation—Losartan—hypertension	6.87e-05	0.000183	CcSEcCtD
Glycopyrrolate—Vomiting—Eplerenone—hypertension	6.87e-05	0.000183	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Furosemide—hypertension	6.86e-05	0.000183	CcSEcCtD
Glycopyrrolate—Rash—Fosinopril—hypertension	6.85e-05	0.000182	CcSEcCtD
Glycopyrrolate—Dermatitis—Fosinopril—hypertension	6.84e-05	0.000182	CcSEcCtD
Glycopyrrolate—Vomiting—Nifedipine—hypertension	6.82e-05	0.000182	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Furosemide—hypertension	6.81e-05	0.000181	CcSEcCtD
Glycopyrrolate—Rash—Eplerenone—hypertension	6.81e-05	0.000181	CcSEcCtD
Glycopyrrolate—Urticaria—Perindopril—hypertension	6.81e-05	0.000181	CcSEcCtD
Glycopyrrolate—Headache—Fosinopril—hypertension	6.81e-05	0.000181	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Trandolapril—hypertension	6.81e-05	0.000181	CcSEcCtD
Glycopyrrolate—Dermatitis—Eplerenone—hypertension	6.8e-05	0.000181	CcSEcCtD
Glycopyrrolate—Asthenia—Clonidine—hypertension	6.8e-05	0.000181	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Betaxolol—hypertension	6.79e-05	0.000181	CcSEcCtD
Glycopyrrolate—Confusional state—Timolol—hypertension	6.79e-05	0.000181	CcSEcCtD
Glycopyrrolate—Vomiting—Verapamil—hypertension	6.79e-05	0.000181	CcSEcCtD
Glycopyrrolate—Urticaria—Irbesartan—hypertension	6.78e-05	0.000181	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Enalapril—hypertension	6.78e-05	0.000181	CcSEcCtD
Glycopyrrolate—Abdominal pain—Perindopril—hypertension	6.77e-05	0.00018	CcSEcCtD
Glycopyrrolate—Body temperature increased—Perindopril—hypertension	6.77e-05	0.00018	CcSEcCtD
Glycopyrrolate—Palpitations—Lisinopril—hypertension	6.77e-05	0.00018	CcSEcCtD
Glycopyrrolate—Headache—Eplerenone—hypertension	6.76e-05	0.00018	CcSEcCtD
Glycopyrrolate—Rash—Nifedipine—hypertension	6.76e-05	0.00018	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Ramipril—hypertension	6.76e-05	0.00018	CcSEcCtD
Glycopyrrolate—Dermatitis—Nifedipine—hypertension	6.75e-05	0.00018	CcSEcCtD
Glycopyrrolate—Abdominal pain—Irbesartan—hypertension	6.75e-05	0.00018	CcSEcCtD
Glycopyrrolate—Body temperature increased—Irbesartan—hypertension	6.75e-05	0.00018	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Timolol—hypertension	6.74e-05	0.000179	CcSEcCtD
Glycopyrrolate—Oedema—Timolol—hypertension	6.74e-05	0.000179	CcSEcCtD
Glycopyrrolate—Rash—Verapamil—hypertension	6.73e-05	0.000179	CcSEcCtD
Glycopyrrolate—Urticaria—Hydrochlorothiazide—hypertension	6.73e-05	0.000179	CcSEcCtD
Glycopyrrolate—Tachycardia—Ramipril—hypertension	6.72e-05	0.000179	CcSEcCtD
Glycopyrrolate—Dermatitis—Verapamil—hypertension	6.72e-05	0.000179	CcSEcCtD
Glycopyrrolate—Headache—Nifedipine—hypertension	6.71e-05	0.000179	CcSEcCtD
Glycopyrrolate—Pruritus—Clonidine—hypertension	6.7e-05	0.000178	CcSEcCtD
Glycopyrrolate—Abdominal pain—Hydrochlorothiazide—hypertension	6.69e-05	0.000178	CcSEcCtD
Glycopyrrolate—Body temperature increased—Hydrochlorothiazide—hypertension	6.69e-05	0.000178	CcSEcCtD
Glycopyrrolate—Skin disorder—Ramipril—hypertension	6.69e-05	0.000178	CcSEcCtD
Glycopyrrolate—Infection—Timolol—hypertension	6.69e-05	0.000178	CcSEcCtD
Glycopyrrolate—Headache—Verapamil—hypertension	6.69e-05	0.000178	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Telmisartan—hypertension	6.69e-05	0.000178	CcSEcCtD
Glycopyrrolate—Nausea—Indapamide—hypertension	6.67e-05	0.000178	CcSEcCtD
Glycopyrrolate—Nausea—Diltiazem—hypertension	6.67e-05	0.000178	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Ramipril—hypertension	6.66e-05	0.000177	CcSEcCtD
Glycopyrrolate—Asthenia—Trandolapril—hypertension	6.63e-05	0.000177	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Losartan—hypertension	6.62e-05	0.000176	CcSEcCtD
Glycopyrrolate—Urticaria—Furosemide—hypertension	6.62e-05	0.000176	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Timolol—hypertension	6.61e-05	0.000176	CcSEcCtD
Glycopyrrolate—Nausea—Carvedilol—hypertension	6.61e-05	0.000176	CcSEcCtD
Glycopyrrolate—Asthenia—Enalapril—hypertension	6.6e-05	0.000176	CcSEcCtD
Glycopyrrolate—Abdominal pain—Furosemide—hypertension	6.58e-05	0.000175	CcSEcCtD
Glycopyrrolate—Body temperature increased—Furosemide—hypertension	6.58e-05	0.000175	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Losartan—hypertension	6.57e-05	0.000175	CcSEcCtD
Glycopyrrolate—Dizziness—Valsartan—hypertension	6.57e-05	0.000175	CcSEcCtD
Glycopyrrolate—Urticaria—Betaxolol—hypertension	6.55e-05	0.000174	CcSEcCtD
Glycopyrrolate—Skin disorder—Timolol—hypertension	6.54e-05	0.000174	CcSEcCtD
Glycopyrrolate—Dizziness—Olmesartan—hypertension	6.54e-05	0.000174	CcSEcCtD
Glycopyrrolate—Pruritus—Trandolapril—hypertension	6.54e-05	0.000174	CcSEcCtD
Glycopyrrolate—Nausea—Doxazosin—hypertension	6.53e-05	0.000174	CcSEcCtD
Glycopyrrolate—Body temperature increased—Betaxolol—hypertension	6.52e-05	0.000174	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Timolol—hypertension	6.51e-05	0.000173	CcSEcCtD
Glycopyrrolate—Asthenia—Telmisartan—hypertension	6.51e-05	0.000173	CcSEcCtD
Glycopyrrolate—Pruritus—Enalapril—hypertension	6.51e-05	0.000173	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—hypertension	6.47e-05	0.000172	CcSEcCtD
Glycopyrrolate—Nausea—Fosinopril—hypertension	6.45e-05	0.000172	CcSEcCtD
Glycopyrrolate—Hypotension—Ramipril—hypertension	6.44e-05	0.000171	CcSEcCtD
Glycopyrrolate—Pruritus—Telmisartan—hypertension	6.42e-05	0.000171	CcSEcCtD
Glycopyrrolate—Nausea—Eplerenone—hypertension	6.41e-05	0.000171	CcSEcCtD
Glycopyrrolate—Urticaria—Losartan—hypertension	6.38e-05	0.00017	CcSEcCtD
Glycopyrrolate—Dry mouth—Lisinopril—hypertension	6.38e-05	0.00017	CcSEcCtD
Glycopyrrolate—Nausea—Nifedipine—hypertension	6.37e-05	0.00017	CcSEcCtD
Glycopyrrolate—Abdominal pain—Losartan—hypertension	6.35e-05	0.000169	CcSEcCtD
Glycopyrrolate—Body temperature increased—Losartan—hypertension	6.35e-05	0.000169	CcSEcCtD
Glycopyrrolate—Nausea—Verapamil—hypertension	6.34e-05	0.000169	CcSEcCtD
Glycopyrrolate—Asthenia—Captopril—hypertension	6.33e-05	0.000169	CcSEcCtD
Glycopyrrolate—Vomiting—Valsartan—hypertension	6.32e-05	0.000168	CcSEcCtD
Glycopyrrolate—Confusional state—Lisinopril—hypertension	6.3e-05	0.000168	CcSEcCtD
Glycopyrrolate—Hypotension—Timolol—hypertension	6.29e-05	0.000168	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Irbesartan—hypertension	6.29e-05	0.000168	CcSEcCtD
Glycopyrrolate—Vomiting—Olmesartan—hypertension	6.29e-05	0.000167	CcSEcCtD
Glycopyrrolate—Rash—Valsartan—hypertension	6.26e-05	0.000167	CcSEcCtD
Glycopyrrolate—Dizziness—Clonidine—hypertension	6.26e-05	0.000167	CcSEcCtD
Glycopyrrolate—Dermatitis—Valsartan—hypertension	6.26e-05	0.000167	CcSEcCtD
Glycopyrrolate—Oedema—Lisinopril—hypertension	6.25e-05	0.000166	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Lisinopril—hypertension	6.25e-05	0.000166	CcSEcCtD
Glycopyrrolate—Pruritus—Captopril—hypertension	6.24e-05	0.000166	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Hydrochlorothiazide—hypertension	6.24e-05	0.000166	CcSEcCtD
Glycopyrrolate—Rash—Olmesartan—hypertension	6.23e-05	0.000166	CcSEcCtD
Glycopyrrolate—Insomnia—Ramipril—hypertension	6.23e-05	0.000166	CcSEcCtD
Glycopyrrolate—Dermatitis—Olmesartan—hypertension	6.23e-05	0.000166	CcSEcCtD
Glycopyrrolate—Headache—Valsartan—hypertension	6.22e-05	0.000166	CcSEcCtD
Glycopyrrolate—Infection—Lisinopril—hypertension	6.21e-05	0.000165	CcSEcCtD
Glycopyrrolate—Headache—Olmesartan—hypertension	6.19e-05	0.000165	CcSEcCtD
Glycopyrrolate—Asthenia—Perindopril—hypertension	6.15e-05	0.000164	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Furosemide—hypertension	6.14e-05	0.000163	CcSEcCtD
Glycopyrrolate—Asthenia—Irbesartan—hypertension	6.13e-05	0.000163	CcSEcCtD
Glycopyrrolate—Somnolence—Ramipril—hypertension	6.13e-05	0.000163	CcSEcCtD
Glycopyrrolate—Dizziness—Trandolapril—hypertension	6.11e-05	0.000163	CcSEcCtD
Glycopyrrolate—Tachycardia—Lisinopril—hypertension	6.1e-05	0.000162	CcSEcCtD
Glycopyrrolate—Insomnia—Timolol—hypertension	6.09e-05	0.000162	CcSEcCtD
Glycopyrrolate—Dizziness—Enalapril—hypertension	6.08e-05	0.000162	CcSEcCtD
Glycopyrrolate—Asthenia—Hydrochlorothiazide—hypertension	6.08e-05	0.000162	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Betaxolol—hypertension	6.07e-05	0.000162	CcSEcCtD
Glycopyrrolate—Skin disorder—Lisinopril—hypertension	6.07e-05	0.000162	CcSEcCtD
Glycopyrrolate—Dyspepsia—Ramipril—hypertension	6.07e-05	0.000162	CcSEcCtD
Glycopyrrolate—Pruritus—Perindopril—hypertension	6.06e-05	0.000161	CcSEcCtD
Glycopyrrolate—Pruritus—Irbesartan—hypertension	6.04e-05	0.000161	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Lisinopril—hypertension	6.04e-05	0.000161	CcSEcCtD
Glycopyrrolate—Vomiting—Clonidine—hypertension	6.02e-05	0.00016	CcSEcCtD
Glycopyrrolate—Dizziness—Telmisartan—hypertension	6e-05	0.00016	CcSEcCtD
Glycopyrrolate—Pruritus—Hydrochlorothiazide—hypertension	5.99e-05	0.00016	CcSEcCtD
Glycopyrrolate—Somnolence—Timolol—hypertension	5.99e-05	0.00016	CcSEcCtD
Glycopyrrolate—Asthenia—Furosemide—hypertension	5.98e-05	0.000159	CcSEcCtD
Glycopyrrolate—Rash—Clonidine—hypertension	5.97e-05	0.000159	CcSEcCtD
Glycopyrrolate—Dermatitis—Clonidine—hypertension	5.97e-05	0.000159	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Ramipril—hypertension	5.95e-05	0.000158	CcSEcCtD
Glycopyrrolate—Fatigue—Ramipril—hypertension	5.94e-05	0.000158	CcSEcCtD
Glycopyrrolate—Headache—Clonidine—hypertension	5.93e-05	0.000158	CcSEcCtD
Glycopyrrolate—Dyspepsia—Timolol—hypertension	5.93e-05	0.000158	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Losartan—hypertension	5.92e-05	0.000158	CcSEcCtD
Glycopyrrolate—Asthenia—Betaxolol—hypertension	5.92e-05	0.000158	CcSEcCtD
Glycopyrrolate—Nausea—Valsartan—hypertension	5.9e-05	0.000157	CcSEcCtD
Glycopyrrolate—Pruritus—Furosemide—hypertension	5.89e-05	0.000157	CcSEcCtD
Glycopyrrolate—Constipation—Ramipril—hypertension	5.89e-05	0.000157	CcSEcCtD
Glycopyrrolate—Nausea—Olmesartan—hypertension	5.87e-05	0.000156	CcSEcCtD
Glycopyrrolate—Vomiting—Trandolapril—hypertension	5.87e-05	0.000156	CcSEcCtD
Glycopyrrolate—Vomiting—Enalapril—hypertension	5.85e-05	0.000156	CcSEcCtD
Glycopyrrolate—Hypotension—Lisinopril—hypertension	5.84e-05	0.000156	CcSEcCtD
Glycopyrrolate—Dizziness—Captopril—hypertension	5.83e-05	0.000155	CcSEcCtD
Glycopyrrolate—Pruritus—Betaxolol—hypertension	5.83e-05	0.000155	CcSEcCtD
Glycopyrrolate—Rash—Trandolapril—hypertension	5.82e-05	0.000155	CcSEcCtD
Glycopyrrolate—Dermatitis—Trandolapril—hypertension	5.82e-05	0.000155	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Timolol—hypertension	5.82e-05	0.000155	CcSEcCtD
Glycopyrrolate—Fatigue—Timolol—hypertension	5.81e-05	0.000155	CcSEcCtD
Glycopyrrolate—Rash—Enalapril—hypertension	5.8e-05	0.000155	CcSEcCtD
Glycopyrrolate—Dermatitis—Enalapril—hypertension	5.8e-05	0.000154	CcSEcCtD
Glycopyrrolate—Headache—Trandolapril—hypertension	5.79e-05	0.000154	CcSEcCtD
Glycopyrrolate—Vomiting—Telmisartan—hypertension	5.77e-05	0.000154	CcSEcCtD
Glycopyrrolate—Asthenia—Losartan—hypertension	5.77e-05	0.000154	CcSEcCtD
Glycopyrrolate—Headache—Enalapril—hypertension	5.76e-05	0.000154	CcSEcCtD
Glycopyrrolate—Pain—Timolol—hypertension	5.76e-05	0.000153	CcSEcCtD
Glycopyrrolate—Rash—Telmisartan—hypertension	5.72e-05	0.000152	CcSEcCtD
Glycopyrrolate—Dermatitis—Telmisartan—hypertension	5.72e-05	0.000152	CcSEcCtD
Glycopyrrolate—Pruritus—Losartan—hypertension	5.69e-05	0.000151	CcSEcCtD
Glycopyrrolate—Headache—Telmisartan—hypertension	5.68e-05	0.000151	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Ramipril—hypertension	5.68e-05	0.000151	CcSEcCtD
Glycopyrrolate—Dizziness—Perindopril—hypertension	5.67e-05	0.000151	CcSEcCtD
Glycopyrrolate—Insomnia—Lisinopril—hypertension	5.65e-05	0.000151	CcSEcCtD
Glycopyrrolate—Dizziness—Irbesartan—hypertension	5.65e-05	0.00015	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Ramipril—hypertension	5.63e-05	0.00015	CcSEcCtD
Glycopyrrolate—Nausea—Clonidine—hypertension	5.63e-05	0.00015	CcSEcCtD
Glycopyrrolate—Vomiting—Captopril—hypertension	5.61e-05	0.000149	CcSEcCtD
Glycopyrrolate—Dizziness—Hydrochlorothiazide—hypertension	5.6e-05	0.000149	CcSEcCtD
Glycopyrrolate—Rash—Captopril—hypertension	5.56e-05	0.000148	CcSEcCtD
Glycopyrrolate—Dermatitis—Captopril—hypertension	5.56e-05	0.000148	CcSEcCtD
Glycopyrrolate—Somnolence—Lisinopril—hypertension	5.56e-05	0.000148	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Timolol—hypertension	5.55e-05	0.000148	CcSEcCtD
Glycopyrrolate—Headache—Captopril—hypertension	5.53e-05	0.000147	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Timolol—hypertension	5.51e-05	0.000147	CcSEcCtD
Glycopyrrolate—Dizziness—Furosemide—hypertension	5.51e-05	0.000147	CcSEcCtD
Glycopyrrolate—Dyspepsia—Lisinopril—hypertension	5.5e-05	0.000147	CcSEcCtD
Glycopyrrolate—Nausea—Trandolapril—hypertension	5.49e-05	0.000146	CcSEcCtD
Glycopyrrolate—Urticaria—Ramipril—hypertension	5.47e-05	0.000146	CcSEcCtD
Glycopyrrolate—Nausea—Enalapril—hypertension	5.46e-05	0.000146	CcSEcCtD
Glycopyrrolate—Dizziness—Betaxolol—hypertension	5.45e-05	0.000145	CcSEcCtD
Glycopyrrolate—Vomiting—Perindopril—hypertension	5.45e-05	0.000145	CcSEcCtD
Glycopyrrolate—Body temperature increased—Ramipril—hypertension	5.45e-05	0.000145	CcSEcCtD
Glycopyrrolate—Abdominal pain—Ramipril—hypertension	5.45e-05	0.000145	CcSEcCtD
Glycopyrrolate—Vomiting—Irbesartan—hypertension	5.43e-05	0.000145	CcSEcCtD
Glycopyrrolate—Rash—Perindopril—hypertension	5.4e-05	0.000144	CcSEcCtD
Glycopyrrolate—Dermatitis—Perindopril—hypertension	5.4e-05	0.000144	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Lisinopril—hypertension	5.39e-05	0.000144	CcSEcCtD
Glycopyrrolate—Nausea—Telmisartan—hypertension	5.39e-05	0.000144	CcSEcCtD
Glycopyrrolate—Fatigue—Lisinopril—hypertension	5.39e-05	0.000144	CcSEcCtD
Glycopyrrolate—Vomiting—Hydrochlorothiazide—hypertension	5.38e-05	0.000143	CcSEcCtD
Glycopyrrolate—Rash—Irbesartan—hypertension	5.38e-05	0.000143	CcSEcCtD
Glycopyrrolate—Dermatitis—Irbesartan—hypertension	5.38e-05	0.000143	CcSEcCtD
Glycopyrrolate—Headache—Perindopril—hypertension	5.37e-05	0.000143	CcSEcCtD
Glycopyrrolate—Urticaria—Timolol—hypertension	5.35e-05	0.000143	CcSEcCtD
Glycopyrrolate—Headache—Irbesartan—hypertension	5.35e-05	0.000142	CcSEcCtD
Glycopyrrolate—Constipation—Lisinopril—hypertension	5.34e-05	0.000142	CcSEcCtD
Glycopyrrolate—Pain—Lisinopril—hypertension	5.34e-05	0.000142	CcSEcCtD
Glycopyrrolate—Rash—Hydrochlorothiazide—hypertension	5.34e-05	0.000142	CcSEcCtD
Glycopyrrolate—Dermatitis—Hydrochlorothiazide—hypertension	5.33e-05	0.000142	CcSEcCtD
Glycopyrrolate—Body temperature increased—Timolol—hypertension	5.32e-05	0.000142	CcSEcCtD
Glycopyrrolate—Abdominal pain—Timolol—hypertension	5.32e-05	0.000142	CcSEcCtD
Glycopyrrolate—Dizziness—Losartan—hypertension	5.31e-05	0.000142	CcSEcCtD
Glycopyrrolate—Headache—Hydrochlorothiazide—hypertension	5.31e-05	0.000141	CcSEcCtD
Glycopyrrolate—Vomiting—Furosemide—hypertension	5.3e-05	0.000141	CcSEcCtD
Glycopyrrolate—Rash—Furosemide—hypertension	5.25e-05	0.00014	CcSEcCtD
Glycopyrrolate—Dermatitis—Furosemide—hypertension	5.25e-05	0.00014	CcSEcCtD
Glycopyrrolate—Vomiting—Betaxolol—hypertension	5.24e-05	0.00014	CcSEcCtD
Glycopyrrolate—Nausea—Captopril—hypertension	5.24e-05	0.00014	CcSEcCtD
Glycopyrrolate—Headache—Furosemide—hypertension	5.22e-05	0.000139	CcSEcCtD
Glycopyrrolate—Rash—Betaxolol—hypertension	5.2e-05	0.000138	CcSEcCtD
Glycopyrrolate—Dermatitis—Betaxolol—hypertension	5.19e-05	0.000138	CcSEcCtD
Glycopyrrolate—Headache—Betaxolol—hypertension	5.17e-05	0.000138	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Lisinopril—hypertension	5.15e-05	0.000137	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Lisinopril—hypertension	5.11e-05	0.000136	CcSEcCtD
Glycopyrrolate—Vomiting—Losartan—hypertension	5.11e-05	0.000136	CcSEcCtD
Glycopyrrolate—Nausea—Perindopril—hypertension	5.09e-05	0.000136	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Ramipril—hypertension	5.08e-05	0.000135	CcSEcCtD
Glycopyrrolate—Nausea—Irbesartan—hypertension	5.07e-05	0.000135	CcSEcCtD
Glycopyrrolate—Rash—Losartan—hypertension	5.07e-05	0.000135	CcSEcCtD
Glycopyrrolate—Dermatitis—Losartan—hypertension	5.06e-05	0.000135	CcSEcCtD
Glycopyrrolate—Headache—Losartan—hypertension	5.03e-05	0.000134	CcSEcCtD
Glycopyrrolate—Nausea—Hydrochlorothiazide—hypertension	5.03e-05	0.000134	CcSEcCtD
Glycopyrrolate—Urticaria—Lisinopril—hypertension	4.96e-05	0.000132	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Timolol—hypertension	4.96e-05	0.000132	CcSEcCtD
Glycopyrrolate—Nausea—Furosemide—hypertension	4.95e-05	0.000132	CcSEcCtD
Glycopyrrolate—Asthenia—Ramipril—hypertension	4.94e-05	0.000132	CcSEcCtD
Glycopyrrolate—Abdominal pain—Lisinopril—hypertension	4.94e-05	0.000132	CcSEcCtD
Glycopyrrolate—Body temperature increased—Lisinopril—hypertension	4.94e-05	0.000132	CcSEcCtD
Glycopyrrolate—Nausea—Betaxolol—hypertension	4.9e-05	0.00013	CcSEcCtD
Glycopyrrolate—Pruritus—Ramipril—hypertension	4.87e-05	0.00013	CcSEcCtD
Glycopyrrolate—Asthenia—Timolol—hypertension	4.83e-05	0.000129	CcSEcCtD
Glycopyrrolate—Nausea—Losartan—hypertension	4.77e-05	0.000127	CcSEcCtD
Glycopyrrolate—Pruritus—Timolol—hypertension	4.77e-05	0.000127	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Lisinopril—hypertension	4.6e-05	0.000123	CcSEcCtD
Glycopyrrolate—Dizziness—Ramipril—hypertension	4.56e-05	0.000121	CcSEcCtD
Glycopyrrolate—Asthenia—Lisinopril—hypertension	4.48e-05	0.000119	CcSEcCtD
Glycopyrrolate—Dizziness—Timolol—hypertension	4.45e-05	0.000119	CcSEcCtD
Glycopyrrolate—Pruritus—Lisinopril—hypertension	4.42e-05	0.000118	CcSEcCtD
Glycopyrrolate—Vomiting—Ramipril—hypertension	4.38e-05	0.000117	CcSEcCtD
Glycopyrrolate—Rash—Ramipril—hypertension	4.34e-05	0.000116	CcSEcCtD
Glycopyrrolate—Dermatitis—Ramipril—hypertension	4.34e-05	0.000116	CcSEcCtD
Glycopyrrolate—Headache—Ramipril—hypertension	4.32e-05	0.000115	CcSEcCtD
Glycopyrrolate—Vomiting—Timolol—hypertension	4.28e-05	0.000114	CcSEcCtD
Glycopyrrolate—Rash—Timolol—hypertension	4.25e-05	0.000113	CcSEcCtD
Glycopyrrolate—Dermatitis—Timolol—hypertension	4.24e-05	0.000113	CcSEcCtD
Glycopyrrolate—Headache—Timolol—hypertension	4.22e-05	0.000112	CcSEcCtD
Glycopyrrolate—Dizziness—Lisinopril—hypertension	4.13e-05	0.00011	CcSEcCtD
Glycopyrrolate—Nausea—Ramipril—hypertension	4.09e-05	0.000109	CcSEcCtD
Glycopyrrolate—Nausea—Timolol—hypertension	4e-05	0.000107	CcSEcCtD
Glycopyrrolate—Vomiting—Lisinopril—hypertension	3.97e-05	0.000106	CcSEcCtD
Glycopyrrolate—Rash—Lisinopril—hypertension	3.94e-05	0.000105	CcSEcCtD
Glycopyrrolate—Dermatitis—Lisinopril—hypertension	3.94e-05	0.000105	CcSEcCtD
Glycopyrrolate—Headache—Lisinopril—hypertension	3.91e-05	0.000104	CcSEcCtD
Glycopyrrolate—Nausea—Lisinopril—hypertension	3.71e-05	9.89e-05	CcSEcCtD
Glycopyrrolate—CHRM3—Signaling Pathways—CCL5—hypertension	7.32e-06	3.63e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—EDN1—hypertension	7.31e-06	3.62e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—INS—hypertension	7.31e-06	3.62e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CCL5—hypertension	7.25e-06	3.59e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—CALM1—hypertension	7.2e-06	3.57e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CCL2—hypertension	7.19e-06	3.56e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—LPL—hypertension	7.18e-06	3.56e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—APOE—hypertension	7.18e-06	3.56e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—LPL—hypertension	7.16e-06	3.55e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—H2AFX—hypertension	7.13e-06	3.53e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—RPS6KB1—hypertension	7.12e-06	3.53e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PDGFRB—hypertension	7.12e-06	3.53e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—CAV1—hypertension	7.11e-06	3.52e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—H2AFX—hypertension	7.11e-06	3.52e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PDGFRB—hypertension	7.1e-06	3.52e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—RPS6KB1—hypertension	7.1e-06	3.52e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—APOA1—hypertension	7.1e-06	3.52e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—LPL—hypertension	7.09e-06	3.51e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—IGF1—hypertension	7.07e-06	3.5e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—AKT2—hypertension	7.06e-06	3.5e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—H2AFX—hypertension	7.04e-06	3.49e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—ADCY5—hypertension	7.03e-06	3.48e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—EGFR—hypertension	7.03e-06	3.48e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PDGFRB—hypertension	7.03e-06	3.48e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—RPS6KB1—hypertension	7.03e-06	3.48e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—ADCY5—hypertension	7.01e-06	3.47e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—SERPINE1—hypertension	7.01e-06	3.47e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PRKCG—hypertension	6.99e-06	3.46e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PRKCG—hypertension	6.96e-06	3.45e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—ADCY5—hypertension	6.94e-06	3.44e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—ITGB3—hypertension	6.94e-06	3.44e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PRKCA—hypertension	6.94e-06	3.44e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—ITGB3—hypertension	6.92e-06	3.43e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PRKCA—hypertension	6.92e-06	3.43e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PRKCG—hypertension	6.9e-06	3.42e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—YWHAZ—hypertension	6.88e-06	3.41e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—YWHAZ—hypertension	6.86e-06	3.4e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—ITGB3—hypertension	6.85e-06	3.39e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PRKCA—hypertension	6.85e-06	3.39e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—NGF—hypertension	6.8e-06	3.37e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—SPP1—hypertension	6.8e-06	3.37e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—YWHAZ—hypertension	6.79e-06	3.37e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—FGF2—hypertension	6.78e-06	3.36e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—NGF—hypertension	6.78e-06	3.36e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—SPP1—hypertension	6.78e-06	3.36e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—CXCL8—hypertension	6.77e-06	3.36e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—RHOA—hypertension	6.76e-06	3.35e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—CXCL8—hypertension	6.75e-06	3.35e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—NGF—hypertension	6.72e-06	3.33e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—SPP1—hypertension	6.72e-06	3.33e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—SERPINE1—hypertension	6.71e-06	3.32e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—PIK3R1—hypertension	6.69e-06	3.31e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—NOS3—hypertension	6.69e-06	3.31e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—CXCL8—hypertension	6.69e-06	3.31e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CCR5—hypertension	6.62e-06	3.28e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PRKCD—hypertension	6.62e-06	3.28e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CCR5—hypertension	6.6e-06	3.27e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PRKCD—hypertension	6.6e-06	3.27e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CCR5—hypertension	6.53e-06	3.24e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PRKCD—hypertension	6.53e-06	3.24e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—FGF2—hypertension	6.5e-06	3.22e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—HTR2A—hypertension	6.48e-06	3.21e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—RHOA—hypertension	6.47e-06	3.21e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—C3—hypertension	6.47e-06	3.2e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—HTR2A—hypertension	6.46e-06	3.2e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—C3—hypertension	6.45e-06	3.19e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—PIK3R1—hypertension	6.41e-06	3.17e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—NOS3—hypertension	6.41e-06	3.17e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—HTR2A—hypertension	6.39e-06	3.17e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—C3—hypertension	6.39e-06	3.16e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—RELA—hypertension	6.3e-06	3.12e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PDGFB—hypertension	6.3e-06	3.12e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PDGFB—hypertension	6.28e-06	3.11e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—FGFR1—hypertension	6.26e-06	3.1e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PPARG—hypertension	6.25e-06	3.1e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—FGFR1—hypertension	6.24e-06	3.09e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PDGFB—hypertension	6.22e-06	3.08e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—FGFR1—hypertension	6.18e-06	3.06e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—MTOR—hypertension	6.18e-06	3.06e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—HIF1A—hypertension	6.17e-06	3.06e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—POMC—hypertension	6.17e-06	3.06e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—HIF1A—hypertension	6.15e-06	3.05e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—AGT—hypertension	6.15e-06	3.04e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—INS—hypertension	6.13e-06	3.04e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—AGT—hypertension	6.13e-06	3.03e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—HIF1A—hypertension	6.09e-06	3.02e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—AGT—hypertension	6.07e-06	3.01e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CALM1—hypertension	6.04e-06	2.99e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—RELA—hypertension	6.03e-06	2.99e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CALM1—hypertension	6.02e-06	2.98e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—APOE—hypertension	6.02e-06	2.98e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—LEP—hypertension	6.02e-06	2.98e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—LEP—hypertension	6e-06	2.97e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—APOE—hypertension	6e-06	2.97e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CAV1—hypertension	5.97e-06	2.96e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CALM1—hypertension	5.97e-06	2.96e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—APOA1—hypertension	5.95e-06	2.95e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CAV1—hypertension	5.95e-06	2.95e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—LEP—hypertension	5.94e-06	2.94e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—APOE—hypertension	5.94e-06	2.94e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CXCL8—hypertension	5.94e-06	2.94e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—APOA1—hypertension	5.93e-06	2.94e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—MTOR—hypertension	5.91e-06	2.93e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—KDR—hypertension	5.9e-06	2.92e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CAV1—hypertension	5.89e-06	2.92e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—KDR—hypertension	5.88e-06	2.91e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—APOA1—hypertension	5.88e-06	2.91e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—KDR—hypertension	5.82e-06	2.88e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—AKT1—hypertension	5.73e-06	2.84e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CXCL8—hypertension	5.68e-06	2.82e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—F2—hypertension	5.68e-06	2.81e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PRKCB—hypertension	5.68e-06	2.81e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—FN1—hypertension	5.68e-06	2.81e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PRKCB—hypertension	5.66e-06	2.8e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—F2—hypertension	5.66e-06	2.8e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—FN1—hypertension	5.66e-06	2.8e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—IL6—hypertension	5.64e-06	2.8e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—ALB—hypertension	5.62e-06	2.79e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—FN1—hypertension	5.61e-06	2.78e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PRKCB—hypertension	5.61e-06	2.78e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—F2—hypertension	5.61e-06	2.78e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—NOTCH1—hypertension	5.56e-06	2.75e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—NOTCH1—hypertension	5.54e-06	2.74e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—AKT1—hypertension	5.49e-06	2.72e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—NOTCH1—hypertension	5.49e-06	2.72e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—IL6—hypertension	5.4e-06	2.68e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—NOS3—hypertension	5.38e-06	2.66e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PIK3R1—hypertension	5.38e-06	2.66e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—MMP9—hypertension	5.37e-06	2.66e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CDKN1A—hypertension	5.35e-06	2.65e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—PTEN—hypertension	5.34e-06	2.64e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—MAPK8—hypertension	5.22e-06	2.59e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—AKT1—hypertension	5.21e-06	2.58e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—POMC—hypertension	5.17e-06	2.56e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—POMC—hypertension	5.16e-06	2.55e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—INS—hypertension	5.14e-06	2.55e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—MMP9—hypertension	5.14e-06	2.55e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—INS—hypertension	5.13e-06	2.54e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CDKN1A—hypertension	5.12e-06	2.54e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—PTEN—hypertension	5.11e-06	2.53e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—POMC—hypertension	5.11e-06	2.53e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—EP300—hypertension	5.09e-06	2.52e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—INS—hypertension	5.08e-06	2.52e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CCL2—hypertension	5.06e-06	2.51e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CCL2—hypertension	5.05e-06	2.5e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—MAPK8—hypertension	5e-06	2.48e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CCL2—hypertension	5e-06	2.48e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—AKT1—hypertension	4.99e-06	2.47e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—IGF1—hypertension	4.98e-06	2.47e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—AKT2—hypertension	4.97e-06	2.46e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—IGF1—hypertension	4.96e-06	2.46e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—AKT2—hypertension	4.96e-06	2.46e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—EGFR—hypertension	4.95e-06	2.45e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—SRC—hypertension	4.95e-06	2.45e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—EGFR—hypertension	4.94e-06	2.45e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PTGS2—hypertension	4.92e-06	2.44e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—IGF1—hypertension	4.91e-06	2.43e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—AKT2—hypertension	4.91e-06	2.43e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—EGFR—hypertension	4.89e-06	2.42e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—EP300—hypertension	4.87e-06	2.41e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—VEGFA—hypertension	4.82e-06	2.39e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—SRC—hypertension	4.74e-06	2.35e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—SERPINE1—hypertension	4.73e-06	2.34e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—SERPINE1—hypertension	4.71e-06	2.33e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—SERPINE1—hypertension	4.66e-06	2.31e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—VEGFA—hypertension	4.62e-06	2.29e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—FGF2—hypertension	4.57e-06	2.27e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—FGF2—hypertension	4.56e-06	2.26e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—RHOA—hypertension	4.56e-06	2.26e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—RHOA—hypertension	4.54e-06	2.25e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—FGF2—hypertension	4.52e-06	2.24e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—NOS3—hypertension	4.51e-06	2.23e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PIK3R1—hypertension	4.51e-06	2.23e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—RHOA—hypertension	4.5e-06	2.23e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PIK3R1—hypertension	4.5e-06	2.23e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—NOS3—hypertension	4.5e-06	2.23e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PIK3R1—hypertension	4.45e-06	2.21e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—NOS3—hypertension	4.45e-06	2.21e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—MYC—hypertension	4.44e-06	2.2e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—TGFB1—hypertension	4.42e-06	2.19e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—EGFR—hypertension	4.34e-06	2.15e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PTEN—hypertension	4.29e-06	2.13e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—MYC—hypertension	4.25e-06	2.1e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—RELA—hypertension	4.25e-06	2.1e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—TGFB1—hypertension	4.24e-06	2.1e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—RELA—hypertension	4.23e-06	2.1e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—RELA—hypertension	4.19e-06	2.08e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—MTOR—hypertension	4.16e-06	2.06e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—EGFR—hypertension	4.15e-06	2.06e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—MTOR—hypertension	4.15e-06	2.06e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—MTOR—hypertension	4.11e-06	2.04e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—EP300—hypertension	4.09e-06	2.03e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CXCL8—hypertension	4e-06	1.98e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CXCL8—hypertension	3.99e-06	1.98e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CXCL8—hypertension	3.95e-06	1.96e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—AKT1—hypertension	3.87e-06	1.92e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—AKT1—hypertension	3.85e-06	1.91e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—AKT1—hypertension	3.82e-06	1.89e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—IL6—hypertension	3.81e-06	1.89e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—IL6—hypertension	3.79e-06	1.88e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—IL6—hypertension	3.76e-06	1.86e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—TP53—hypertension	3.64e-06	1.8e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—MMP9—hypertension	3.62e-06	1.79e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—MMP9—hypertension	3.61e-06	1.79e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CDKN1A—hypertension	3.61e-06	1.79e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PTEN—hypertension	3.6e-06	1.78e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CDKN1A—hypertension	3.6e-06	1.78e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PTEN—hypertension	3.59e-06	1.78e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—MMP9—hypertension	3.57e-06	1.77e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CDKN1A—hypertension	3.56e-06	1.76e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PTEN—hypertension	3.55e-06	1.76e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—MAPK8—hypertension	3.52e-06	1.74e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—AKT1—hypertension	3.51e-06	1.74e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—MAPK8—hypertension	3.51e-06	1.74e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—AKT1—hypertension	3.5e-06	1.73e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—TP53—hypertension	3.49e-06	1.73e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—MAPK8—hypertension	3.48e-06	1.72e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—AKT1—hypertension	3.47e-06	1.72e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—EP300—hypertension	3.43e-06	1.7e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—EP300—hypertension	3.42e-06	1.69e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—EP300—hypertension	3.39e-06	1.68e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—SRC—hypertension	3.34e-06	1.65e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—IL6—hypertension	3.33e-06	1.65e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—SRC—hypertension	3.33e-06	1.65e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—SRC—hypertension	3.29e-06	1.63e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—VEGFA—hypertension	3.25e-06	1.61e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—VEGFA—hypertension	3.24e-06	1.6e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—VEGFA—hypertension	3.21e-06	1.59e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—IL6—hypertension	3.19e-06	1.58e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—AKT1—hypertension	3.08e-06	1.52e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—MYC—hypertension	2.99e-06	1.48e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—TGFB1—hypertension	2.98e-06	1.48e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—MYC—hypertension	2.98e-06	1.48e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—TGFB1—hypertension	2.97e-06	1.47e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—MYC—hypertension	2.95e-06	1.46e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—AKT1—hypertension	2.95e-06	1.46e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—TGFB1—hypertension	2.95e-06	1.46e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—EGFR—hypertension	2.93e-06	1.45e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—EGFR—hypertension	2.92e-06	1.44e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—EGFR—hypertension	2.89e-06	1.43e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—AKT1—hypertension	2.47e-06	1.22e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—TP53—hypertension	2.46e-06	1.22e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—TP53—hypertension	2.45e-06	1.21e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—TP53—hypertension	2.42e-06	1.2e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—IL6—hypertension	2.25e-06	1.11e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—IL6—hypertension	2.24e-06	1.11e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—IL6—hypertension	2.22e-06	1.1e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—AKT1—hypertension	2.07e-06	1.03e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—AKT1—hypertension	2.07e-06	1.02e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—AKT1—hypertension	2.05e-06	1.01e-05	CbGpPWpGaD
